ML

Mark Levin

Partner at Third Rock Ventures

Boston, Massachusetts

Overview 

Mark Levin is the Chairman of the Board of Directors at The Possible Zone in Boston, Massachusetts. With a background that includes serving as the CEO and Chairman of the Board at Millennium, as well as being a Partner at third rock ventures, Levin has made significant contributions to the biotech sector, investing in companies like Corvia Medical and NinePoint Medical. Mark Levin's career highlights include his leadership roles at Millennium and his current position as Chairman of the Board at The Possible Zone, where he continues to make impactful investments in Series B and Series A companies in the biotech sector in Boston/New England.

Work Experience 

TP

The Possible Zone

  • Chairman Of The Board Of Directors

    2009 - Current

    High School Entrepreneurship Program, partnering with High School Students, in preparation for careers of the future

tr

third rock ventures

  • Partner

    2007

    Founding and Building Biotech Companies to develop products that will make a difference in patients lives

millennium

  • CEO, Chairman of Board and Board Member

    1993 - 2008

    Founding and Building a Personalized Medicine Company to identify the cause of human diseases and develop breakthrough products for patients

mayfield fund

  • partner

    1987 - 1993

    Founding and building of Biotech companies to develop products for making a difference in patients lives

G

Genentech

  • Leader of Process Engineering and Project leader on multiple R and D Programs

    1981 - 1987

    Developing/scaling processes for the manufacture of protein therapeutics derived from genetic engineering

Genentech specializes in genetic testing and personalized medicine.

gene.com

Foxboro

  • Head Of Marketing

    1979 - 1981

    Head of Marketing to the Pharma Sector for Foxboro, a process Control Computer Company

Miller Brewing Company

  • Startup Engineer and Production Manager

    1977 - 1979

    Startup Team for new brewery and then Shift Production Manager

EL

Eli Lilly and Company

  • Process Development Engineer

    1974 - 1977

    Developing new processes for R and D products moving into commercialization

Eli Lilly engages in the discovery, development, manufacture, and sale of pharmaceutical products.

Raised $6,500,000.00.

lilly.com

Education 

Investments 

Corvia Medical

Series C

Total funding: $45M

NinePoint Medical

Series A

Total funding: $67M

Articles About Mark

Relevant Websites